What is Zacks Research’s Estimate for NKTR Q1 Earnings?
Stock analysts at Zacks Research issued their Q1 2027 earnings estimates for Nektar Therapeutics in a research report issued on Wednesday, April 2nd. Zacks Research analyst K. Das forecasts that the ...
Nektar Therapeutics (NASDAQ:NKTR) Receives $4.92 Consensus Price Target from Brokerages
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has been assigned a consensus recommendation of “Buy” from the seven ...
US close: Stocks end Q1's final session mostly higher
Major indices turned in a mixed performance on Monday as market participants patiently awaited clarity on Donald Trump's ...
US open: Stocks lower as Trump's tariffs remain firmly in focus
Major indices were in the red early on Monday as market participants patiently awaited clarity on Donald Trump's planned ...